Cingulate Warrants Company Insiders
| CINGW Stock | USD 0.05 0.0001 0.21% |
Cingulate Warrants employs about 13 people. The company is managed by 9 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 1.44 employees per reported executive. Recap of Cingulate Warrants' management performance can provide insight into the venture performance.
Cingulate |
Cingulate Warrants Management Team Effectiveness
The company has return on total asset (ROA) of (1.0433) % which means that it has lost $1.0433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7382) %, meaning that it generated substantial loss on money invested by shareholders. Cingulate Warrants' management efficiency ratios could be used to measure how well Cingulate Warrants manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cingulate Warrants' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 3.60 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (6.40). At this time, Cingulate Warrants' Non Currrent Assets Other are fairly stable compared to the past year. Debt To Assets is likely to climb to 0.90 in 2024, whereas Total Assets are likely to drop slightly above 3.3 M in 2024.Common Stock Shares Outstanding is likely to drop to about 71.7 K in 2024
Cingulate Warrants Workforce Comparison
Cingulate Warrants is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 388. Cingulate Warrants holds roughly 13.0 in number of employees claiming about 3% of equities under Health Care industry.
Cingulate Warrants Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cingulate Warrants insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cingulate Warrants' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cingulate Warrants insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jennifer Callahan over a week ago Acquisition by Jennifer Callahan of 22459 shares of Cingulate Warrants at 6.0 subject to Rule 16b-3 | ||
Van Horn Louis G over two months ago Discretionary transaction by Van Horn Louis G of tradable shares of Cingulate Warrants subject to Rule 16b-3 | ||
Gilgallon Craig S. over three months ago Acquisition by Gilgallon Craig S. of 3575 shares of Cingulate Warrants at 0.84 subject to Rule 16b-3 | ||
Medeiros Curtis over six months ago Acquisition by Medeiros Curtis of 9000 shares of Cingulate Warrants at 1.38 subject to Rule 16b-3 | ||
Gallagher Patrick Joseph over six months ago Disposition of tradable shares by Gallagher Patrick Joseph of Cingulate Warrants subject to Rule 16b-3 | ||
Applebaum Scott over six months ago Insider Trading |
Cingulate Warrants Notable Stakeholders
A Cingulate Warrants stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cingulate Warrants often face trade-offs trying to please all of them. Cingulate Warrants' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cingulate Warrants' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Shane PharmD | CEO Board | Profile | |
| PharmD PharmD | Principal CEO | Profile | |
| Jennifer CPA | Senior CFO | Profile | |
| Dr MBA | Executive COO | Profile | |
| Craig Esq | Gen VP | Profile | |
| Raul MD | Executive Officer | Profile | |
| Thomas Dalton | Head Relations | Profile | |
| Jennifer Callahan | Corporate Controller | Profile | |
| Matthew MD | Executive Officer | Profile |
About Cingulate Warrants Management Performance
The success or failure of an entity such as Cingulate Warrants often depends on how effective the management is. Cingulate Warrants management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cingulate management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cingulate management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (6.74) | (6.40) | |
| Return On Capital Employed | 3.38 | 3.55 | |
| Return On Assets | (6.74) | (6.40) | |
| Return On Equity | 3.43 | 3.60 |
Please note, the imprecision that can be found in Cingulate Warrants' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cingulate Warrants. Check Cingulate Warrants' Beneish M Score to see the likelihood of Cingulate Warrants' management manipulating its earnings.
Cingulate Warrants Workforce Analysis
Traditionally, organizations such as Cingulate Warrants use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cingulate Warrants within its industry.Cingulate Warrants Manpower Efficiency
Return on Cingulate Warrants Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.8K | |
| Net Loss Per Executive | 2.6K | |
| Working Capital Per Employee | 65.9K | |
| Working Capital Per Executive | 95.2K |
Additional Tools for Cingulate Stock Analysis
When running Cingulate Warrants' price analysis, check to measure Cingulate Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate Warrants is operating at the current time. Most of Cingulate Warrants' value examination focuses on studying past and present price action to predict the probability of Cingulate Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate Warrants' price. Additionally, you may evaluate how the addition of Cingulate Warrants to your portfolios can decrease your overall portfolio volatility.